Clinical-Stage Biotech

BOSTON, Massachusetts, and Seoul, South Korea — August 18, 2026 Ingenia Therapeutics announced that its shares have begun trading...

INDIANAPOLIS, June 24, 2026 Eli Lilly and Company announced the successful completion of its acquisition of Centessa Pharmaceuticals plc,...

TAIPEI, Taiwan, SHANGHAI, China and SAN FRANCISCO, California — May 28, 2026 HanchorBio, Inc. announced that the company will...

Paris, France and Cambridge, Massachusetts, USA, May 22, 2026 Nanobiotix, a late-stage clinical biotechnology company specializing in physics-based cancer...

WILMINGTON, Del. & SAN FRANCISCO, May 19, 2026 Incyte and Edison Scientific have announced a strategic collaboration aimed at...

SAN ANTONIO, Texas, May 19, 2026 Valion Bio, Inc. has announced a high-level joint engagement with senior officials from...

CARY, N.C. and BRADENTON, Fla., May 20, 2026 Continuity Biosciences has announced the initiation of a Phase I first-in-human...

CAMBRIDGE, Mass., May 20, 2026 MetaVia Inc. has announced the publication of new peer-reviewed preclinical research supporting the anti-fibrotic...

MIRAMAR, FLORIDA, UNITED STATES — February 17, 2026 HCW Biologics announced the pricing of a $1.5 million follow-on public...

Montreal, Canada | January 29, 2026 — Repare Therapeutics Inc., a clinical-stage precision oncology company, has completed its previously...